E. Marshall

928 total citations
21 papers, 493 citations indexed

About

E. Marshall is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E. Marshall has authored 21 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E. Marshall's work include Neutropenia and Cancer Infections (5 papers), Immunotherapy and Immune Responses (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). E. Marshall is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Immunotherapy and Immune Responses (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). E. Marshall collaborates with scholars based in United Kingdom, Canada and Australia. E. Marshall's co-authors include Bertil Damato, David B. Smith, S.M. O'Reilly, Peter Clark, V. Kelly, Helen Innes, Peter Salmon, Sebastian A. Cook, Nora Hunter and G. T. O'Neill and has published in prestigious journals such as Nature, Science and Journal of Clinical Oncology.

In The Last Decade

E. Marshall

20 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Marshall United Kingdom 11 233 164 133 104 73 21 493
Mark P. Breazzano United States 12 54 0.2× 72 0.4× 349 2.6× 14 0.1× 23 0.3× 75 522
Ankona Banerjee United States 12 71 0.3× 109 0.7× 35 0.3× 57 0.5× 4 0.1× 31 541
Esko Aine Finland 16 55 0.2× 84 0.5× 339 2.5× 36 0.3× 5 0.1× 23 690
Leslie S. Jones United States 9 105 0.5× 60 0.4× 174 1.3× 70 0.7× 19 524
Yahya Alzahrani Saudi Arabia 12 18 0.1× 43 0.3× 233 1.8× 14 0.1× 8 0.1× 38 459
Amira Yasmine Benmelouka Egypt 11 50 0.2× 57 0.3× 5 0.0× 33 0.3× 27 0.4× 26 344
Vicki Santos United States 9 45 0.2× 32 0.2× 85 0.6× 39 0.4× 3 0.0× 18 426
Laura M. Tanner Finland 14 52 0.2× 112 0.7× 3 0.0× 112 1.1× 130 1.8× 34 602
Jun‐ichi Azumi Japan 10 36 0.2× 111 0.7× 7 0.1× 85 0.8× 8 0.1× 24 332
Jonathan Wild United Kingdom 10 86 0.4× 97 0.6× 5 0.0× 21 0.2× 5 0.1× 25 399

Countries citing papers authored by E. Marshall

Since Specialization
Citations

This map shows the geographic impact of E. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Marshall more than expected).

Fields of papers citing papers by E. Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Marshall. The network helps show where E. Marshall may publish in the future.

Co-authorship network of co-authors of E. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of E. Marshall. A scholar is included among the top collaborators of E. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Marshall. E. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badawi, Alaa, et al.. (2024). 2050 Scoping an Oncogeriatric Pathway in Acute Care. Age and Ageing. 53(Supplement_1). 1 indexed citations
2.
3.
Marshall, E.. (2019). Ambulatory management in low risk neutropenic sepsis – A plea for integrated acute cancer care. Acute Medicine Journal. 18(1). 6–7. 11 indexed citations
4.
Sage, Adam P., Kevin W. Ng, E. Marshall, et al.. (2018). MA24.06 Long Non-Coding Rna Expression Patterns Delineate Infiltrating Immune Cells in the Lung Tumour Microenvironment. Journal of Thoracic Oncology. 13(10). S443–S444. 2 indexed citations
5.
Nathan, Paul, Victoria M.L. Cohen, Sarah E. Coupland, et al.. (2015). Uveal Melanoma UK National Guidelines. European Journal of Cancer. 51(16). 2404–2412. 89 indexed citations
6.
7.
8.
Butts, Charles, H Anderson, Andrew W. Maksymiuk, et al.. (2009). Long-term safety of BLP25 liposome vaccine (L-BLP25) in patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). 3055–3055. 13 indexed citations
9.
Cook, Sebastian A., Bertil Damato, E. Marshall, & Peter Salmon. (2008). Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye. 23(3). 581–585. 51 indexed citations
10.
Billingham, Lucinda, et al.. (2005). Management of febrile neutropenia in the United Kingdom: time for a national trial?. British Journal of Cancer. 93(12). 1324–1328. 13 indexed citations
11.
Murray, Nevin, Charles Butts, Andrew W. Maksymiuk, et al.. (2005). A liposomal MUC1 vaccine for treatment of non-small cell lung cancer (NSCLC): Updated survival results from patients with stage IIIB disease. Journal of Clinical Oncology. 23(16_suppl). 7037–7037. 6 indexed citations
12.
Soulières, Denis, Nevin Murray, Andrew W. Maksymiuk, et al.. (2005). A liposomal MUC1 vaccine for treatment of non-small cell lung cancer (NSCLC): Differences in QOL assessments for Stage IIIBLR and IV patients. Journal of Clinical Oncology. 23(16_suppl). 7209–7209. 2 indexed citations
13.
14.
O'Neill, G. T., et al.. (2003). Characterization of ovine PrP gene promoter activity in N2a neuroblastoma and ovine foetal brain cell lines. Journal of Animal Breeding and Genetics. 120(2). 114–123. 12 indexed citations
15.
Kelly, Ayano, et al.. (2002). Assessment and management of fatigue in patients with advanced cancer: developing guidelines. International Journal of Palliative Nursing. 8(8). 381–388. 8 indexed citations
16.
Hunter, Nora, Wilfred Goldmann, E. Marshall, & G. T. O'Neill. (2000). Sheep and goats: natural and experimental TSEs and factors influencing incidence of disease. PubMed. 181–188. 26 indexed citations
17.
Marshall, E.. (1995). Gene therapy's growing pains. Nature. 269. 1050–1055. 91 indexed citations
18.
Marshall, E.. (1995). Breast cancer. Reanalysis confirms results of 'tainted' study.. PubMed. 270(5242). 1562–1562. 3 indexed citations
19.
Wilkinson, Greg, et al.. (1993). The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychological Medicine. 23(1). 229–237. 45 indexed citations
20.
Metcalf, Cecily, et al.. (1992). Extranodal Ki‐1 lymphoma in a renal transplant patient. Australian and New Zealand Journal of Medicine. 22(1). 51–53. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark P. Breazzano Breakdown of academic impact, for papers by Ankona Banerjee Breakdown of academic impact, for papers by Esko Aine Breakdown of academic impact, for papers by Leslie S. Jones Breakdown of academic impact, for papers by Yahya Alzahrani Breakdown of academic impact, for papers by Amira Yasmine Benmelouka Breakdown of academic impact, for papers by Vicki Santos Breakdown of academic impact, for papers by Laura M. Tanner Breakdown of academic impact, for papers by Jun‐ichi Azumi Breakdown of academic impact, for papers by Jonathan Wild
Rankless by CCL
2026